UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico

Neurología (Barcelona, Spain), 2015-04, Vol.30 (3), p.163-168

2015

Volltextzugriff (PDF)

Microvascular decompression may be effective for refractory SUNCT regardless of symptom duration

Cephalalgia, 2010-05, Vol.30 (5), p.626-630

2010

Volltextzugriff (PDF)

Estudio observacional retrospectivo sobre la efectividad del ácido 5-aminolevulínico en la cirugía de los gliomas malignos en España (Estudio VISIONA)

Neurología (Barcelona, Spain), 2014-04, Vol.29 (3), p.131-138

2014

Volltextzugriff (PDF)

Creation of a human central nervous system tumor bank using heterotopic xenografts

Brain & spine, 2021, Vol.1, p.100797, Article 100797

2021

Volltextzugriff (PDF)

Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery

Neurología (Barcelona, English ed. ), 2015-04, Vol.30 (3), p.163-168

2015

Volltextzugriff (PDF)

Infratentorial hygroma secondary to decompressive craniectomy after cerebellar infarction

Neurocirugía (Asturias, Spain), 2009-10, Vol.20 (5), p.470-473

2009

Volltextzugriff (PDF)

Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)

Neurología (Barcelona, English ed. ), 2014-04, Vol.29 (3), p.131-138

2014

Volltextzugriff (PDF)

Results expected in 5-ALA-guided resection of glioblastoma

European journal of surgical oncology, 2014-08, Vol.40 (8), p.1021-1022

2014

Volltextzugriff (PDF)

Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)

Neurologia (Barcelona, Spain), 2014-04, Vol.29 (3), p.131

2014

Volltextzugriff (PDF)

Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery

Neurologia (Barcelona, Spain), 2015-04, Vol.30 (3), p.163

2015

Volltextzugriff (PDF)

O6.03 A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE <<DEND/GBM>> TRIAL

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii12-ii13

2014

Volltextzugriff (PDF)

P17.15.A THANK PHASE I TRIAL OF DNX-2440 ONCOLYTIC ADENOVIRUS IN PATIENTS WITH FIRST OR SECOND RECURRENCE OF GLIOBLASTOMA: PRELIMINARY RESULTS

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii120-ii120

2023

Volltextzugriff (PDF)

P17.14.B PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii120-ii120

2023

Volltextzugriff (PDF)

OS5.1 Phase I clinical trial with oncolytic virus DNX-2401 for DIPGs

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii11-iii11

2019

Volltextzugriff (PDF)

Meningeal melanocytoma with malignant behaviour

Neurologia (Barcelona, Spain), 2011-11, Vol.26 (9), p.565

2011

Volltextzugriff (PDF)

OS1.1 Role of RNU6-1 isolated from circulating exosomes as a differential biomarker for GBM versus non-neoplasic brain lesions and PCNSL

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii216-iii217

2018

Volltextzugriff (PDF)

P01.061 Autologous dendritic cells vaccination and standard radio-chemotherapy in patients with newly diagnosed glioblastoma: a retrospective single-center series

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii243-iii243

2018

Volltextzugriff (PDF)

Melanocitoma meníngeo con comportamiento maligno

Neurología (Barcelona, Spain), 2011-11, Vol.26 (9), p.565-566

2011

Volltextzugriff (PDF)

P01.092 Salvage Frameless Stereotactic Radiosurgery as first treatment option for recurrent brain metastases. May durable intracranial control be achieved?

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii251-iii252

2018

Volltextzugriff (PDF)

P01.096 Hypofractionated radiotherapy and temozolomide in patients with glioblastoma and poor prognostic factors other than age - is it worth it?

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii253-iii253

2018

Volltextzugriff (PDF)

Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning

European journal of nuclear medicine and molecular imaging, 2012-05, Vol.39 (5), p.771-781

2012

Volltextzugriff (PDF)

O6.03A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE «DEND/GBM» TRIAL

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (Suppl 2), p.ii12-ii13

2014

Volltextzugriff (PDF)

Analysis of Recurrence and Survival Patterns in High Grade Glioma Treated with External Beam (3D-CRT) and Stereotactic Radiotherapy (SRT) Combined with Concurrent Temozolomide and Carboplatin

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S238-S238

2008

Volltextzugriff (PDF)

Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas

Neuropathology and applied neurobiology, 2014-10, Vol.40 (6), p.736-746

2014

Volltextzugriff (PDF)

SC-01 HnRNPA1 PROTEIN DEREGULATES Baf45d mRNA SPLICING IN GLIOMA: FUNCTION AND MECHANISM

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v197-v197

2014

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)
Bücher
(1)

Sprache

Englisch
(34)
Spanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico

Microvascular decompression may be effective for refractory SUNCT regardless of symptom duration

Estudio observacional retrospectivo sobre la efectividad del ácido 5-aminolevulínico en la cirugía de los gliomas malignos en España (Estudio VISIONA)

Creation of a human central nervous system tumor bank using heterotopic xenografts

Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery

Infratentorial hygroma secondary to decompressive craniectomy after cerebellar infarction

Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)

Results expected in 5-ALA-guided resection of glioblastoma

Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)

Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery

O6.03 A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE <<DEND/GBM>> TRIAL

P17.15.A THANK PHASE I TRIAL OF DNX-2440 ONCOLYTIC ADENOVIRUS IN PATIENTS WITH FIRST OR SECOND RECURRENCE OF GLIOBLASTOMA: PRELIMINARY RESULTS

P17.14.B PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

OS5.1 Phase I clinical trial with oncolytic virus DNX-2401 for DIPGs

Meningeal melanocytoma with malignant behaviour

OS1.1 Role of RNU6-1 isolated from circulating exosomes as a differential biomarker for GBM versus non-neoplasic brain lesions and PCNSL

P01.061 Autologous dendritic cells vaccination and standard radio-chemotherapy in patients with newly diagnosed glioblastoma: a retrospective single-center series

Melanocitoma meníngeo con comportamiento maligno

P01.092 Salvage Frameless Stereotactic Radiosurgery as first treatment option for recurrent brain metastases. May durable intracranial control be achieved?

P01.096 Hypofractionated radiotherapy and temozolomide in patients with glioblastoma and poor prognostic factors other than age - is it worth it?

Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning

O6.03A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE «DEND/GBM» TRIAL

Analysis of Recurrence and Survival Patterns in High Grade Glioma Treated with External Beam (3D-CRT) and Stereotactic Radiotherapy (SRT) Combined with Concurrent Temozolomide and Carboplatin

Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas

SC-01 HnRNPA1 PROTEIN DEREGULATES Baf45d mRNA SPLICING IN GLIOMA: FUNCTION AND MECHANISM

Suchergebnisse filtern